Document Detail


Therapeutic potential of melatonin in traumatic central nervous system injury.
MedLine Citation:
PMID:  19627458     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A vast literature extolling the benefits of melatonin has accumulated during the past four decades. Melatonin was previously considered of importance to seasonal reproduction and circadian rhythmicity. Currently, it appears to be a versatile anti-oxidative and anti-nitrosative agent, a molecule with immunomodulatory actions and profound oncostatic activity, and also to play a role as a potent neuroprotectant. Nowadays, melatonin is sold as a dietary supplement with differential availability as an over-the-counter aid in different countries. There is a widespread agreement that melatonin is nontoxic and safe considering its frequent, long-term usage by humans at both physiological and pharmacological doses with no reported side effects. Endeavors toward a designated drug status for melatonin may be enormously rewarding in clinics for treatment of several forms of neurotrauma where effective pharmacological intervention has not yet been attained. This mini review consolidates the data regarding the efficacy of melatonin as an unique neuroprotective agent in traumatic central nervous system (CNS) injuries. Well-documented actions of melatonin in combating traumatic CNS damage are compiled from various clinical and experimental studies. Research on traumatic brain injury and ischemia/reperfusion are briefly outlined here as they have been recently reviewed elsewhere, whereas the studies on different animal models of the experimental spinal cord injury have been extensively covered in this mini review for the first time.
Authors:
Supriti Samantaray; Arabinda Das; Nakul P Thakore; Denise D Matzelle; Russel J Reiter; Swapan K Ray; Naren L Banik
Related Documents :
8668378 - Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury.
2036278 - A 7-year review of maxillofacial trauma in a central london hospital.
1221258 - The performance of seat belts in severe crashes.
10367148 - Self awareness: effects of feedback and review on verbal self reports and remembering f...
19422408 - Reviewing deaths in the emergency department: deaths in the department or deaths within...
21577148 - Bilateral sacroiliac joint dislocation (anterior and posterior) with triradiate cartila...
Publication Detail:
Type:  Journal Article; Review     Date:  2009-07-13
Journal Detail:
Title:  Journal of pineal research     Volume:  47     ISSN:  1600-079X     ISO Abbreviation:  J. Pineal Res.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-19     Completed Date:  2009-11-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8504412     Medline TA:  J Pineal Res     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  134-42     Citation Subset:  IM    
Affiliation:
Division of Neurology, Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Central Nervous System / injuries*
Humans
Melatonin / therapeutic use*
Neuroprotective Agents / therapeutic use*
Trauma, Nervous System / drug therapy*
Chemical
Reg. No./Substance:
0/Neuroprotective Agents; 73-31-4/Melatonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Melatonin reduces cardiac inflammatory injury induced by acute exercise.
Next Document:  Melatonin downregulates nuclear erythroid 2-related factor 2 and nuclear factor-kappaB during preven...